To maximise total return by investing in companies around the world with innovative products, processes or services, including those companies whose provision or use of technology gives them a strategic advantage in the market.
Name | % Net Assets |
---|---|
Oracle | 4.3% |
4.1% | |
Johnson & Johnson | 4.0% |
Cisco Systems | 3.8% |
Microsoft | 3.6% |
Astellas Pharma | 3.6% |
Amgen | 3.4% |
Schering-Plough | 3.4% |
Macdonald Dettwile | 3.3% |
Siemens | 2.9% |
Key | % Net Assets |
---|---|
Oracle | 4.3% |
4.1% | |
Johnson & Johnson | 4.0% |
Cisco Systems | 3.8% |
Other | 83.8% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 04/10/1999 |
---|---|
Fund Manager | Cyrille Filott |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | -0.06 |
You are here: research